Neural Stem/progenitor Cell Transplantation for Spinal Cord Injury Treatment; A Systematic Review and Meta-analysis

Overview

Journal Neuroscience

Specialty Neurology

Date 2016 Feb 27

PMID 26917272

Citations 94

Authors

M Yousefifard

V Rahimi-Movaghar

F Nasirinezhad

M Baikpour

S Safari

S Saadat

A Moghadas Jafari

H Asady

S M T Razavi Tousi

M Hosseini

Affiliations

Soon will be listed here.

Abstract

Despite the vast improvements of cell therapy in spinal cord injury treatment, no optimum protocol has been developed for application of neural stem/progenitor cells. In this regard, the present meta-analysis showed that the efficacy of the neural stem/progenitor cell (NSPC) transplantation depends mainly on injury model, intervention phase, transplanted cell count, immunosuppressive use, and probably stem cell source. Improved functional recovery post NSPC transplantation was found to be higher in transection and contusion models. Moreover, NSPC transplantation in acute phase of spinal injury was found to have better functional recovery. Higher doses (>3×10(6)cell/kg) were also shown to be optimum for transplantation, but immunosuppressive agent administration negatively affected the motor function recovery. Scaffold use in NSPC transplantation could also effectively raise functional recovery.

Citing Articles

Using magnetic resonance relaxometry to evaluate the safety and quality of induced pluripotent stem cell-derived spinal cord progenitor cells.

Tan J, Chen J, Roxby D, Chooi W, Nguyen T, Ng S Stem Cell Res Ther. 2024; 15(1):465.

PMID: 39639398 PMC: 11622678. DOI: 10.1186/s13287-024-04070-y.

Therapeutic Transplantation of Human Central Nervous System Organoids for Neural Reconstruction.

Hong S, Bock M, Zhang S, An S, Han I Int J Mol Sci. 2024; 25(15).

PMID: 39126108 PMC: 11313261. DOI: 10.3390/ijms25158540.

Advances and Challenges in Spinal Cord Injury Treatments.

Alvi M, Pedro K, Quddusi A, Fehlings M J Clin Med. 2024; 13(14).

PMID: 39064141 PMC: 11278467. DOI: 10.3390/jcm13144101.

Is the Hedgehog Pathway Involved in the Pathophysiology of Schizophrenia? A Systematic Review of Current Evidence of Neural Molecular Correlates and Perspectives on Drug Development.

Del Casale A, Modesti M, Gentile G, Guariglia C, Ferracuti S, Simmaco M Curr Issues Mol Biol. 2024; 46(6):5322-5336.

PMID: 38920990 PMC: 11202070. DOI: 10.3390/cimb46060318.

Treatment of Syringomyelia Characterized by Focal Dilatation of the Central Canal Using Mesenchymal Stem Cells and Neural Stem Cells.

Li M, Wang X, Qi B, Cui S, Zheng T, Guan Y Tissue Eng Regen Med. 2024; 21(4):625-639.

PMID: 38578425 PMC: 11087409. DOI: 10.1007/s13770-024-00637-1.